Okeanis Eco Tankers Corp. (ECO)

G1 Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	362.25	393.23	413.1	270.97	169	282.87
Revenue Growth (YoY)	-12.00%	-4.81%	52.45%	60.34%	-40.26%	121.45%
Cost of Revenue	171.55	169.63	151.3	109.83	85.7	88.29
Gross Profit	190.71	223.6	261.8	161.15	83.3	194.58
Selling, General & Admin	19.36	19.52	20.29	13.06	12.75	11.59
Operating Expenses	60.56	60.65	60.67	51.02	51.42	53.21
Operating Income	130.15	162.94	201.12	110.12	31.88	141.36
Interest Expense	-51.46	-55.89	-60.68	-27.5	-27.19	-36.89
Interest & Investment Income	3.17	3.45	4.1	0.72	0	0.05
Currency Exchange Gain (Loss)	-0.13	-0.75	0.67	0.32	-0.06	0.05
Other Non Operating Income (Expenses)	-1.43	-2.72	0.03	0.9	-1.59	-1.9
EBT Excluding Unusual Items	80.3	107.03	145.25	84.56	3.05	102.67
Gain (Loss) on Sale of Assets	-	-	-	-	0.14	-
Legal Settlements	-	-	-	-	-	-1.35
Other Unusual Items	-0.44	1.83	-	-	-4.09	-
Pretax Income	79.86	108.86	145.25	84.56	-0.9	101.32
Net Income	79.86	108.86	145.25	84.56	-0.9	101.32
Net Income to Common	79.86	108.86	145.25	84.56	-0.9	101.32
Net Income Growth	-40.93%	-25.05%	71.77%	-	-	789.98%
Shares Outstanding (Basic)	32	32	32	32	32	32
Shares Outstanding (Diluted)	32	32	32	32	32	32
Shares Change (YoY)	-	-	-0.03%	-0.53%	-0.28%	0.62%
EPS (Basic)	2.48	3.38	4.51	2.63	-0.03	3.12
EPS (Diluted)	2.48	3.38	4.51	2.63	-0.03	3.12
EPS Growth	-40.93%	-25.05%	71.82%	-	-	784.52%
Free Cash Flow	100.43	162.82	174.03	-96.08	8.21	-19.96
Free Cash Flow Per Share	3.12	5.06	5.41	-2.98	0.25	-0.61
Dividend Per Share	0.670	0.350	-	-	-	1.450
Gross Margin	52.64%	56.86%	63.37%	59.47%	49.29%	68.79%
Operating Margin	35.93%	41.44%	48.69%	40.64%	18.86%	49.97%
Profit Margin	22.05%	27.68%	35.16%	31.21%	-0.53%	35.82%
Free Cash Flow Margin	27.72%	41.40%	42.13%	-35.46%	4.86%	-7.06%
EBITDA	167.71	200.44	238.64	148.09	70.55	180.26
EBITDA Margin	46.30%	50.97%	57.77%	54.65%	41.74%	63.73%
D&A For EBITDA	37.56	37.49	37.52	37.96	38.67	38.9
EBIT	130.15	162.94	201.12	110.12	31.88	141.36
EBIT Margin	35.93%	41.44%	48.69%	40.64%	18.86%	49.97%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q